Reviews
Blood and marrow stem cell transplants in autoimmune disease. A consensus report written on behalf of the European League Against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT)
A Tyndall and A Gratwohl
| You have reached the most complete version of this article accessible without further authentication.
More complete versions are available. Link to article |
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R Saccardi, T Kozak, C Bocelli-Tyndall, A Fassas, A Kazis, E Havrdova, E Carreras, A Saiz, B Lowenberg, P A. te Boekhorst, et al. Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database Multiple Sclerosis, November 1, 2006; 12(6): 814 - 823. [Abstract] [PDF]
|
|
|
|
 |
|
 D Talaulikar, K E Tymms, I Prosser, and R Smith Autologous peripheral blood stem cell transplantation with in vivo T-cell depletion for life threatening refractory systemic lupus erythematosus Lupus, February 1, 2005; 14(2): 159 - 163. [Abstract] [PDF]
|
|
|
|
|
|
I A Lisukov, S A Sizikova, A D Kulagin, I V Kruchkova, A V Gilevich, L P Konenkova, E V Zonova, E R Chernykh, O Y Leplina, T N Sentyakova, et al. High-dose immunosuppression with autologous stem cell transplantation in severe refractory systemic lupus erythematosus Lupus, February 1, 2004; 13(2): 89 - 94. [Abstract] [PDF]
|
|
|
|
 |
|
 P. A. McSweeney, R. A. Nash, K. M. Sullivan, J. Storek, L. J. Crofford, R. Dansey, M. D. Mayes, K. T. McDonagh, J. L. Nelson, T. A. Gooley, et al. High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes Blood, August 13, 2002; 100(5): 1602 - 1610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. Wedderburn, R. Jeffery, H. White, A. Patel, H. Varsani, D. Linch, K. Murray, and P. Woo Autologous stem cell transplantation for paediatric-onset polyarteritis nodosa: changes in autoimmune phenotype in the context of reduced diversity of the T- and B-cell repertoires, and evidence for reversion from the CD45RO+ to RA+ phenotype Rheumatology, November 1, 2001; 40(11): 1299 - 1307. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K P MACHOLD and J S SMOLEN Stem cell transplantation: limits and hopes Ann Rheum Dis, June 1, 2001; 60(6): 548 - 549. [Full Text] [PDF]
|
|
|
|
|
|
M Binks, J R Passweg, D Furst, P McSweeney, K Sullivan, C Besenthal, J Finke, H H Peter, J van Laar, F C Breedveld, et al. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease Ann Rheum Dis, June 1, 2001; 60(6): 577 - 584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A. Papadaki, F. M. Gibson, S. Rizzo, E. C. Gordon-Smith, and J. C. W. Marsh Assessment of bone marrow stem cell reserve and function and stromal cell function in patients with autoimmune cytopenias Blood, November 1, 2000; 96(9): 3272 - 3275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C J HAWKEY, J A SNOWDEN, A LOBO, C BEGLINGER, and A TYNDALL Stem cell transplantation for inflammatory bowel disease: practical and ethical issues Gut, June 1, 2000; 46(6): 869 - 872. [Full Text] [PDF]
|
|
|
|
|
|
L Fouillard, N C Gorin, J P. Laporte, A Leon, J F Brantus, and P Miossec Control of severe systemic lupus erythematosus after high-dose immunusuppressive therapy and transplantation of CD34+ purified autologous stem cells from peripheral blood Lupus, May 1, 1999; 8(4): 320 - 323. [Abstract] [PDF]
|
|
|
|
 |
|
 D.W. van Bekkum Autologous Stem Cell Transplantation for Treatment of Autoimmune Diseases Stem Cells, May 1, 1999; 17(3): 172 - 178. [Full Text]
|
|
|
|
|
|
Y Sherer and Y Shoenfeld Stem cells transplantation-a cure for autoimmune diseases Lupus, March 1, 1998; 7(3): 137 - 140. [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||